Form 6-K PRUDENTIAL PLC For: Aug 12
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For the
month of August, 2026
PRUDENTIAL PUBLIC LIMITED COMPANY
(Translation
of registrant's name into English)
13/F, One International Finance Centre,
1 Harbour View Street, Central,
Hong Kong, China
(Address
of principal executive... (continue reading...)
Form S-8 Protalix BioTherapeutics
Registration No. 333-_______
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT Under THE SECURITIES ACT OF 1933
Protalix BioTherapeutics, Inc.
(Exact name of registrant as specified in its Charter)
Delaware 65-0643773 (State or other jurisdiction (I.R.S. Employer of incorporation or organization) Identification Number) ... (continue reading...)
Form 4 51Talk Online Education For: Aug 06 Filed by: Huang Jack Jiajia
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 6-K Boyd Group Services Inc. For: Aug 12
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of August 2026
Commission File Number: 001-42925
BOYD GROUP SERVICES INC.
(Translation of registrant’s name into English)
1745 Ellice Avenue, Unit C1
Winnipeg, Manitoba, Canada R3H 1A6
(Address of principal executive office)
More SEC Filings
View Older Stories-
Form 13F-HR APG Asset Management For: Jun 30
-
Form D/A Cederberg Greater China
-
Form 8-K Xilio Therapeutics, Inc. For: Aug 12
-
Form 10-Q/A Capstone Holding Corp. For: Sep 30
-
Form 13F-HR Bretton Capital Manageme For: Jun 30
-
Form 6-K PolyPid Ltd. For: Aug 12
-
Form 10-Q/A Capstone Holding Corp. For: Jun 30
-
Form 8-K Altimmune, Inc. For: Aug 12
-
Form 8-A12B/A VALUED ADVISERS TRUST
-
Form 10-Q/A Capstone Holding Corp. For: Mar 31
-
Form 13F-HR APG Asset Management US For: Jun 30
-
Form D/A XN Opportunities LP
-
Form 10-Q Arbutus Biopharma Corp For: Jun 30
-
Form 10-Q Capstone Holding Corp. For: Jun 30
-
Form 8-K Arbutus Biopharma Corp For: Aug 12
-
Form 8-K Local Bounti Corporation For: Aug 12
-
Form 10-Q SideChannel, Inc. For: Jun 30
-
Form 10-Q TScan Therapeutics, Inc. For: Jun 30
-
Form 10-Q SUTRO BIOPHARMA, INC. For: Jun 30
-
Form 6-K Ituran Location & Contro For: Aug 12
-
Form 6-K Adagene Inc. For: Jun 30
-
Form 6-K Global-E Online Ltd. For: Aug 12
-
Form 8-K CTT PHARMACEUTICAL HOLDI For: Aug 11
-
Form 8-K Capstone Holding Corp. For: Aug 07
-
Form 6-K Ming Shing Group Holding For: Aug 12
-
Form 6-K Electra Battery Material For: Aug 12
-
Form 6-K Brainsway Ltd. For: Aug 12
-
Form 144 CAMTEK LTD Filed by: Aviram Lior
-
Form 8-K Milestone Pharmaceutical For: Aug 12
-
Form 8-K Applied Aerospace & Defe For: Aug 12
-
Form D/A Redwheel EAFE Intrinsic
-
Form 10-D First National Master For: Jul 31
-
Form 4 Matador Resources Co For: Aug 10 Filed by: Foran Joseph Wm
-
Form 13F-HR PGGM Investments For: Jun 30
-
Form 6-K RADCOM LTD For: Aug 12
-
Form 8-A12B AMCON DISTRIBUTING CO
-
Form 8-K SUTRO BIOPHARMA, INC. For: Aug 12
-
Form SCHEDULE 13G/A EXELIXIS, INC. Filed by: AQR CAPITAL MANAGEMENT LLC
-
Form 8-K ZION OIL & GAS INC For: Aug 12
-
Form 424B5 ZION OIL & GAS INC
-
Form 10-Q HG Holdings, Inc. For: Jun 30
-
Form 10-Q CYPHERPUNK TECHNOLOGIES For: Jun 30
-
Form 8-K AMCON DISTRIBUTING CO For: Aug 06
-
Form 8-K TScan Therapeutics, Inc. For: Aug 12
-
Form SCHEDULE 13G/A CARMAX INC Filed by: AQR CAPITAL MANAGEMENT LLC
-
Form 13F-HR STOREBRAND ASSET MANAGEM For: Jun 30
-
Form N-PX PFA Pension, Forsikrings For: Jun 30
-
Form 8-K CYPHERPUNK TECHNOLOGIES For: Aug 12
-
Form 4 Paycom Software, Inc. For: Aug 10 Filed by: Boelte Craig E.
-
Form 10-Q Protalix BioTherapeutics For: Jun 30
